In one paragraphArticle in Annals of internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors at 2 institutions in 1 country.
Sriram GubbiNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-9263-1381 Katherine Andrea AraqueNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-2098-2027 Shirisha AvadhanulaCleveland Clinic, Cleveland, Ohio.
Asma AzamNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Roxanne MerkelNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Craig CochranNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Peter Denis BurbeloNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-1717-048X Meryl WaldmanNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Susanne NeumannNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Marvin Carl GershengornNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-6256-6470 Monica SkarulisNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Joanna Klubo-GwiezdzinskaNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-8633-4420 National Institutes of Health · USCleveland Clinic · US
Funding
Studies of Thyroid Function in Health and DiseaseZIEDK075005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KLUBO-GWIEZDZINSKA, JOANNA · 2013 to 2024
$2.3MStudies of Thyroid Function in Health and DiseaseZ01DK075005 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SKARULIS, MONICA · 2005 to 2008
$965kIntramural NIH HHS Z01 DK075005Intramural NIH HHS ZIE DK075005
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Acute DiseaseCyclophosphamideDexamethasoneDrug Administration ScheduleDrug Therapy, CombinationGraves DiseaseHumansImmunosuppressive AgentsMaleMiddle AgedMyxedemaRituximabCyclophosphamideDexamethasoneImmunosuppressive AgentsRituximab
Identifiers
PMID34152827
PMCPMC9473454
OpenAlexW3173263554
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390